Real-time enrollment status for this recurrent endometrial carcinoma clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 9:30 PM UTC
| NCT Number | NCT04469764 |
| Recruiting Status | Recruiting |
| Condition | Recurrent Endometrial Carcinoma |
| Phase | PHASE2 |
| Target Enrollment | 32 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Jonsson Comprehensive Cancer Center |
| Last Updated on CT.gov | July 17, 2026 (Jul 17, 2026) |
As of August 29, 2026: Clinical trial NCT04469764 is currently recruiting participants. This phase2 study for recurrent endometrial carcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Jonsson Comprehensive Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04469764 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04469764 was last updated Jul 17, 2026 (July 17, 2026). HelloStudys verifies this status automatically.